The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse

Biological Psychiatry

Volumn 55, Issue 11, 2004, Pages 1082-1089

  Shepard, Jack D ^a   Bossert, Jennifer M ^a   Liu, Shirley Y ^a   Shaham, Yavin ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

2 adrenoceptors; drug self administration; extinction; incubation; reinstatement; relapse; stress

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BUPRENORPHINE; METHAMPHETAMINE; YOHIMBINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DEPENDENCE; DRUG EFFECT; DRUG RESPONSE; DRUG WITHDRAWAL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; RELAPSE; SHOCK; STRESS; TRAINING; WITHDRAWAL SYNDROME;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTROSHOCK; EXTINCTION, PSYCHOLOGICAL; MALE; METHAMPHETAMINE; MODELS, ANIMAL; RATS; RATS, LONG-EVANS; SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; YOHIMBINE;

EID: 2542491400     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.02.032     Document Type: Article

References (75)

1. Abercrombie E.D., Keller R.W. Jr, Zigmond M.J. Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion Pharmacological and behavioral studies. Neuroscience. 27:1988;897-904
2. Aghajanian G.K., VanderMaelen C.P. Alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons Intracellular studies in vivo. Science. 215:1982;1394-1396
3. Ahmed S.H., Walker J.R., Koob G.F. Persistent increase in the motivation to take heroin in rats with history of drug escalation. Neuropsychopharmacology. 22:2000;413-421
4. Becker C., Hamon M., Benoliel J.J. Prevention by 5-HT1A receptor agonists of restraint stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat. Neuropharmacology. 38:1999;525-532
5. Buczek Y., Le A.D., Wang A., Stewart J., Shaham Y. Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology. 144:1999;183-188
6. Capriles N., Rodaros D., Sorge R.E., Stewart J. A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats. Psychopharmacology. 168:2003;66-74
7. Charney D.S., Heninger G.R., Redmond D.E. Jr. Yohimbine induced anxiety and increased noradrenergic function in humans Effects of diazepam and clonidine. Life Sci. 33:1983;19-29
8. Chopin P., Pellow S., File S.E. The effects of yohimbine on exploratory and locomotor behaviour are attributable to its effects at noradrenaline and not at benzodiazepine receptors. Neuropharmacology. 25:1986;53-57
9. Davis M., Redmond D.E. Jr, Baraban J.M. Noradrenergic agonists and antagonists Effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacology (Berl). 65:1979;111-118
10. De Vries T.J., Schoffelmeer A.N.M., Binnekade R., Raasø H., Vanderschuren L.J.M.J. Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization. Neuropsychopharmacology. 26:2002;18-26
11. de Wit H. Priming effects with drugs and other reinforcers. Exp Clin Psychopharmacol. 4:1996;5-10
12. de Wit H., Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology. 75:1981;134-143
13. Doxey J.C., Lane A.C., Roach A.G., Virdee N.K. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine. Naunyn Schmiedebergs Arch Pharmacol. 325:1984;136-144
14. Epstein D.H., Preston K.L. The reinstatement model and relapse prevention A clinical perspective. Psychopharmacology. 168:2003;31-41
15. Erb S., Hitchcott P.K., Rajabi H., Mueller D., Shaham Y., Stewart J. Alpha-2 adrenergic agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology. 23:2000;138-150
16. Erb S., Salmaso N., Rodaros D., Stewart J. A role for the CRF-containing pathway projecting from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology. 158:2001;360-365
17. Erb S., Shaham Y., Stewart J. Stress reinstates cocaine-seeking behavior after prolonged extinction and drug-free periods. Psychopharmacology. 128:1996;408-412
18. Forray M.I., Bustos G., Gysling K. Regulation of norepinephrine release from the rat bed nucleus of the stria terminalis In vivo microdialysis studies. J Neurosci Res. 50:1997;1040-1046
19. Grimm J.W., Hope B.T., Wise R.A., Shaham Y. Incubation of cocaine craving after withdrawal. Nature. 412:2001;141-142
20. Grimm J.W., Lu L., Hayashi T., Hope B.T., Su T.P., Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine Implications for incubation of cocaine craving. J Neurosci. 23:2003;742-747
21. Grimm J.W., Shaham Y., Hope B.T. Effect of the cocaine and sucrose withdrawal period on extinction behavior, cue-induced reinstatement and protein levels of the dopamine transporter and tyrosine hydroxylase in limbic and cortical areas in rats. Behav Pharmacol. 13:2002;379-388
22. Harrod S.B., Dwoskin L.P., Crooks P.A., Klebaur J.E., Bardo M.T. Lobeline attenuates d-methamphetamine self-administration in rats. J Pharmacol Exp Ther. 298:2001;172-179
23. Highfield D., Yap J., Grimm J., Shalev U., Shaham Y. Repeated lofexidine treatment attenuates stress-induced, but not drug cues-induced reinstatement of a heroin-cocaine mixture (speedball) seeking in rats. Neuropsychopharmacology. 25:2001;320-331
24. Holmberg G., Gershon S. Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacologia. 2:1961;93-106
25. Hubbard J.W., Pfister S.L., Biediger A.M., Herzig T.C., Keeton T.K. The pharmacokinetic properties of yohimbine in the conscious rat. Naunyn Schmiedebergs Arch Pharmacol. 337:1988;583-587
26. Hughes C.E., Habash T., Dykstra L.A., Picker M.J. Discriminative-stimulus effects of morphine in combination with alpha- and beta-noradrenergic agonists and antagonists. Pharmacol Biochem Behav. 53:1996;979-986
27. Jacobsen L.K., Southwick S.M., Kosten T.R. Substance use disorders in patients with posttraumatic stress disorder A review of the literature. Am J Psychiatry. 158:2001;1184-1890
28. Kalivas P.W., McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology. 168:2003;44-56
29. Katz J.L., Higgins S.T. The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology. 168:2003;21-30
30. Khoshbouei H., Cecchi M., Dove S., Javors M., Morilak D.A. Behavioral reactivity to stress Amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacol Biochem Behav. 71:2002;407-417
31. Lang W.J., Gershon S. Effects of psychoactive drugs on yohimbine induced responses in conscious dogs. A proposed screening procedure for anti-anxiety agents. Arch Int Pharmacodyn Ther. 142:1963;457-472
32. Le A.D., Harding S., Juzytsch W., Fletcher P.J., Shaham Y. The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J Neurosci. 22:2002;7844-7849
33. Le A.D., Quan B., Juzystch W., Fletcher P.J., Joharchi N., Shaham Y. Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology. 135:1998;169-174
34. Lee B., Tiefenbacher S., Platt D.M., Spealman R.D. Pharmacological blockade of alpha(2)-arenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys. Neuropsychopharmacology. 29:2004;686-693
35. Leri F., Flores J., Rodaros D., Stewart J. Blockade of stress-induced, but not cocaine-induced reinstatement, by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci. 22:2002;5713-5718
36. Lu L., Dempsey J., Liu S., Bossert J., Shaham Y. A single infusion of BDNF into the ventral tegmental area induces long-lasting potentiation of cocaine-seeking after withdrawal. J Neurosci. 24:2004;1604-1611
37. Lu L, Grimm JW, Dempsey J, Shaham Y (in press): Cocaine seeking over extended withdrawal periods in rats: Different time courses of responding induced by cocaine cues versus cocaine priming over the first 6 months. Psychopharmacology
38. Lu L., Shepard J.D., Scott Hall F., Shaham Y. Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats A review. Neurosci Biobehav Rev. 27:2003;457-491
39. Mantsch J.R., Goeders N.E. Generalization of restraint-induced discriminative stimulus to cocaine. Psychopharamacology. 135:1998;423-426
40. Mantsch J.R., Goeders N.E. Ketoconazole blocks the stress-induced reinstatement of cocaine-seeking behavior in rats Relationship to the discriminative stimulus effects of cocaine. Psychopharmacology. 142:1999;399-407
41. Martin-Fardon R., Ciccocioppo R., Massi M., Weiss F. Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. Neuroreport. 11:2000;1939-1943
42. McDougle C.J., Black J.E., Malison R.T., Zimmermann R.C., Kosten T.R., Heninger G.R., Price L.H. Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry. 51:1994;713-719
43. Miczek K.A., Mutschler N.H., van Erp A.M., Blank A.D., McInerney S.C. D-amphetamine "cue" generalizes to social defeat stress Behavioral sensitization and attenuated accumbens dopamine. Psychopharmacology. 147:1999;190-199
44. Mongeau R., Blier P., de Montigny C. The serotonergic and noradrenergic systems of the hippocampus Their interactions and the effects of antidepressant treatments. Brain Res Rev. 23:1997;145-195
45. Munzar P., Goldberg S.R. Noradrenergic modulation of the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology. 143:1999;293-301
46. Pacak K., Armando I., Komoly S., Fukuhara K., Weise V.K., Holmes C., et al. Hypercortisolemia inhibits yohimbine-induced release of norepinephrine in the posterolateral hypothalamus of conscious rats. Endocrinology. 131:1992;1369-1376
47. Rawson R.A., Anglin M.D., Ling W. Will the methamphetamine problem go away? J Addict Dis. 21:2002;5-19
48. Sanchez C.J., Bailie T.M., Wu W., Li N., Sorg B.A. Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior. Neuroscience. 119:2003;497-505
49. Scatton B., Zivkovic B., Dedek J. Antidopaminergic properties of yohimbine. J Pharmacol Exp Ther. 215:1980;494-499
50. Schroeder B.E., Schiltz C.A., Kelley A.E. Neural activation profile elicited by cues associated with the anxiogenic drug yohimbine differs from that observed for reward-paired cues. Neuropsychopharmacology. 28:2003;14-21
51. Sethy V.H., Winter J.C. Effects of yohimbine and mescaline on punished behavior in the rat. Psychopharmacologia. 23:1972;160-166
52. Shaham Y., Erb S., Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats A review. Brain Res Rev. 33:2000;13-33
53. Shaham Y., Funk D., Erb S., Brown T.J., Walker C.D., Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci. 17:1997;2605-2614
54. Shaham Y., Highfield D., Delfs J.M., Leung S., Stewart J. Clonidine blocks stress-induced reinstatement of heroin seeking in rats An effect independent of the locus coeruleus noradrenergic neurons. Eur J Neurosci. 12:2000;292-302
55. Shaham Y., Shalev U., Lu L., De Wit H., Stewart J. The reinstatement model of drug relapse History, methodology and major findings. Psychopharmacology. 168:2003;3-20
56. Shaham Y., Stewart J. Stress reinstates heroin self-administration behavior in drug-free animals An effect mimicking heroin, not withdrawal. Psychopharmacology. 119:1995;334-341
57. Shalev U., Grimm J.W., Shaham Y. Neurobiology of relapse to heroin and cocaine seeking A review. Pharmacol Rev. 54:2002;1-42
58. Shalev U., Highfield D., Yap J., Shaham Y. Stress and relapse to drug seeking in rats Studies on the generality of the effect. Psychopharmacology. 150:2000;337-346
59. Shalev U., Morales M., Hope B., Yap J., Shaham Y. Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology. 156:2001;98-107
60. Sinha R. How does stress increase risk of drug abuse and relapse. Psychopharmacology. 158:2001;343-359
61. Spealman R.D., Barrett-Larimore R.L., Rowlett J.K., Platt D.M., Khroyan T.V. Pharmacological and environmental determinants of relapse to cocaine-seeking behavior. Pharmacol Biochem Behav. 64:1999;327-336
62. Stefanski R., Lee S.H., Yasar S., Cadet J.L., Goldberg S.R. Lack of persistent changes in the dopaminergic system of rats withdrawn from methamphetamine self-administration. Eur J Pharmacol. 439:2002;59-68
63. Stewart J. Pathways to relapse The neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci. 25:2000;125-136
64. Stine S.M., Grillon C.G., Morgan C.A. 3rd, Kosten T.R., Charney D.S., Krystal J.H. Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine. Psychopharmacology. 154:2001;274-281
65. Stine S.M., Southwick S.M., Petrakis I.L., Kosten T.R., Charney D.S., Krystal J.H. Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiatry. 51:2002;642-651
66. Tanda G., Bassareo V., Di Chiara G. Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat. Psychopharmacology. 123:1996;127-130
67. Tran-Nguyen T.L., Fuchs R.A., Coffey G.P., O'Dell L.E., Baker D.A., Neisewander J.L. Time-dependent changes in cocaine-seeking behavior and dopamine overflow in the amygdala during cocaine withdrawal. Neuropsychopharmacology. 19:1998;48-59
68. Uhlen S., Dambrova M., Nasman J., Schioth H.B., Gu Y., Wikberg-Matsson A., Wikberg J.E. [3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine. Eur J Pharmacol. 343:1998;93-101
69. Virtanen R., Savola J.M., Saano V. Highly selective and specific antago-nism of central and peripheral alpha 2-adrenoceptors by atipamezole. Arch Int Pharmacodyn Ther. 297:1989;190-204
70. Wada T., Fukuda N. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze. Psychopharmacology. 104:1991;444-450
71. Wang X., Cen X., Lu L. Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. Eur J Pharmacol. 432:2001;153-161
72. White D.A., Birkle D.L. The differential effects of prenatal stress in rats on the acoustic startle reflex under baseline conditions and in response to anxiogenic drugs. Psychopharmacology. 154:2001;169-176
73. Winter J.C., Rabin R.A. Yohimbine as a serotonergic agent Evidence from receptor binding and drug discrimination. J Pharmacol Exp Ther. 263:1992;682-689
74. Yokel R.A. Intravenous self-administration Response rates, the effects of pharmacological challenges, and drug preference. Bozarth M.A. Methods of Assessing the Reinforcing properties of Abused Drug. 1987;1-34 Springer-Verlag, New York
75. Yokel R.A., Pickens R. Self-administration of optical isomers of amphetamine and methylamphetamine by rats. J Pharmacol Exp Ther. 187:1973;27-33